 |
 |
Impax Gets Approval For Parkinson's Drug - Generic Version of Sinemet CR 12:46 PM PDT Monday May 17th 2004 Impax Laboratories Inc. said Monday it got its sixth FDA drug approval this year for generic versions of Sinemet CR tablets, which is used to treat Parkinson's disease. Sinemet is currently sold in the United States by Bristol-Myers Squibb. Hayward-based Impax will call its version of the drug Carbidopa/Levodopa Extended Release Tablets. The company said U.S. prescription sales of Sinemet CR and the one currently marketed generic equivalent were $126 million in the 12 months ended Feb. 29. Parkinson's Disease is a progressive degenerative disease of the nerves. Impax currently has 16 applications pending at the FDA, including five tentatively approved, which the company says address approximately $5.3 billion in U.S. market sales for the 12 months ended Feb. 29. SOURCE: San Francisco Business Times, CA http://tinyurl.com/2txty * * * ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn